These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32538088)

  • 1. Discovery of Dihydropyrrolo[1,2-
    Epplin MP; Mohan A; Harris LD; Zhu Z; Strong KL; Bacsa J; Le P; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2020 Jul; 63(14):7569-7600. PubMed ID: 32538088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
    Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 4. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
    Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
    Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.
    Perszyk RE; DiRaddo JO; Strong KL; Low CM; Ogden KK; Khatri A; Vargish GA; Pelkey KA; Tricoire L; Liotta DC; Smith Y; McBain CJ; Traynelis SF
    Mol Pharmacol; 2016 Dec; 90(6):689-702. PubMed ID: 27625038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
    Monaghan DT; Irvine MW; Costa BM; Fang G; Jane DE
    Neurochem Int; 2012 Sep; 61(4):581-92. PubMed ID: 22269804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.
    Ogden KK; Traynelis SF
    Mol Pharmacol; 2013 May; 83(5):1045-56. PubMed ID: 23455314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
    Nouhi M; Zhang X; Yao N; Chergui K
    CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
    Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
    Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
    Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB
    Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355
    [No Abstract]   [Full Text] [Related]  

  • 12. Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.
    Zhang X; Feng ZJ; Chergui K
    Br J Pharmacol; 2014 Aug; 171(16):3938-45. PubMed ID: 24818560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the
    D'Erasmo MP; Akins NS; Ma P; Jing Y; Swanger SA; Sharma SK; Bartsch PW; Menaldino DS; Arcoria PJ; Bui TT; Pons-Bennaceur A; Le P; Allen JP; Ullman EZ; Nocilla KA; Zhang J; Perszyk RE; Kim S; Acker TM; Taz A; Burton SL; Coe K; Fritzemeier RG; Burnashev N; Yuan H; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2023 Sep; 14(17):3059-3076. PubMed ID: 37566734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
    Zimmerman SS; Khatri A; Garnier-Amblard EC; Mullasseril P; Kurtkaya NL; Gyoneva S; Hansen KB; Traynelis SF; Liotta DC
    J Med Chem; 2014 Mar; 57(6):2334-56. PubMed ID: 24512267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel class of negative allosteric modulators of NMDA receptor function.
    Katzman BM; Perszyk RE; Yuan H; Tahirovic YA; Sotimehin AE; Traynelis SF; Liotta DC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5583-8. PubMed ID: 26525866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of NMDA receptors alters neurotransmission in the striatum of a mouse model of Parkinson's disease.
    Feng ZJ; Zhang X; Chergui K
    Exp Neurol; 2014 May; 255():154-60. PubMed ID: 24632480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.
    Alsaad HA; DeKorver NW; Mao Z; Dravid SM; Arikkath J; Monaghan DT
    Neurochem Res; 2019 Jan; 44(1):61-77. PubMed ID: 29651654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.
    Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T
    Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased modulators of NMDA receptors control channel opening and ion selectivity.
    Perszyk RE; Swanger SA; Shelley C; Khatri A; Fernandez-Cuervo G; Epplin MP; Zhang J; Le P; Bülow P; Garnier-Amblard E; Gangireddy PKR; Bassell GJ; Yuan H; Menaldino DS; Liotta DC; Liebeskind LS; Traynelis SF
    Nat Chem Biol; 2020 Feb; 16(2):188-196. PubMed ID: 31959964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
    Volgraf M; Sellers BD; Jiang Y; Wu G; Ly CQ; Villemure E; Pastor RM; Yuen PW; Lu A; Luo X; Liu M; Zhang S; Sun L; Fu Y; Lupardus PJ; Wallweber HJ; Liederer BM; Deshmukh G; Plise E; Tay S; Reynen P; Herrington J; Gustafson A; Liu Y; Dirksen A; Dietz MG; Liu Y; Wang TM; Hanson JE; Hackos D; Scearce-Levie K; Schwarz JB
    J Med Chem; 2016 Mar; 59(6):2760-79. PubMed ID: 26919761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.